Table 3.
Characteristic | COPD-free N=301 | COPD N=55 | p-value |
---|---|---|---|
Age, mean years, (SD) | 43.9 (6.7) | 47.8 (8.4) | <0.01 |
Age Group (Years), n (%) | |||
30-39 | 86 (28.6) | 10 (18.2) | <0.01 |
40-49 | 157 (52.2) | 22 (40.0) | |
≥ 50 | 58 (19.3) | 23 (41.8) | |
Sex, male, n (%) | 118 (39.2) | 28 (50.9) | 0.11 |
Ever smoked, n (%) | 48 (15.9) | 13 (23.6) | 0.16 |
Biomass exposure, n (%) | 118 (39.2) | 17 (30.9) | 0.24 |
History of PTB, n (%) | 67 (22.3) | 15 (27.3) | 0.42 |
Use of ART, n (%) | 295 (98) | 53 (96.4) | 0.45 |
*Baseline CD4 T-cell count, Median cells/ul(IQR) | 177 (82-286) | 154 (62-272) | 0.12 |
*Log pre-treatment HIV RNA, mean copies/ml (SD) | 4.2 (1.2) | 4.1 (1.2) | 0.50 |
Recent CD4 T-cell count, median cells/ul(IQR) | 496 (326-692) | 441 (309-829) | 0.19 |
Recent CD4 T-cell count < 200 cells/ul, n(%) | 25 (8.4) | 10 (18.9) | 0.02 |
Current HIV Viral Load, undetectable, n (%) | 211 (70.3) | 39 (70.9) | 0.93 |
Time elapsed since HIV diagnosis, mean years (SD) | 7.1 (2.5) | 6.9 (2.7) | 0.68 |
SD: Standard Deviation; PTB: Pulmonary Tuberculosis; ART: Antiretroviral Therapy; IQR: Interquartile Range
CD4: cell count and viral load at first presentation for HIV care